CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cefepime Hydrochloride In Plastic Container patents expire, and what generic alternatives are available?
Cefepime Hydrochloride In Plastic Container is a drug marketed by Samson Medcl and is included in one NDA.
The generic ingredient in CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER is cefepime hydrochloride. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefepime Hydrochloride In Plastic Container
A generic version of CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.
Summary for CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 60 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Meiji Seika Pharma Co., Ltd. | Phase 3 |
Linical Co., Ltd. | Phase 2 |
Allecra | Phase 2 |
See all CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER clinical trials
Pharmacology for CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
US Patents and Regulatory Information for CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samson Medcl | CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER | cefepime hydrochloride | POWDER;INTRAVENOUS | 209408-001 | Aug 21, 2018 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |